ANTITHROMBOTIC MANAGEMENT OF ACUTE CORONARY SYNDROME IN PATIENTS WITH ATRIAL FIBRILLATION IN THE INTERMOUNTAIN HEART COLLABORATIVE STUDY

Acute coronary syndrome (ACS) patients benefit from dual antiplatelet therapy (DAPT), and most patients with atrial fibrillation (AF) merit anticoagulation stroke prophylaxis (AcP). Real world reporting of overall antithrombotic therapy among patients with ACS + AF is limited. We describe